現代牧業(01117.HK):蒙牛乳業發行1億美元可交換公司股份的可換股債券
格隆匯6月18日丨現代牧業(01117.HK)發佈公告,公司接獲中國蒙牛乳業有限公司通知,指蒙牛乳業已與中銀國際亞洲有限公司及國泰君安證券(香港)有限公司訂立日期為2020年6月17日的認購協議,內容有關蒙牛乳業發行(於2023年到期)本金總額為1億美元的可換股債券,該債券可交換為公司股本中每股面值0.10港元的普通股。
如果該債券按照初步名義交換價(每股股份1.2625港元)全數交換為股份,該債券將可交換6.14億股股份(可予以調整),相當於公司在本公告日期已發行股本約9.58%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.